The Problem

Many high-value bioactive compounds used in foods, beverages, dietary supplements, and nutraceuticals suffer from poor solubility and limited bioavailability, leading to inconsistent absorption, reduced functional performance, and diminished consumer-perceived benefits. These limitations constrain product efficacy, increase required dosage levels, and contribute to higher formulation costs, making it difficult for companies to differentiate offerings in increasingly crowded health and wellness markets. At the same time, manufacturers must meet rising expectations for clean labeling, safety, and regulatory acceptance without introducing complex or disruptive technologies.

ArGol Innovative Solution

This innovation delivers a commercially scalable platform designed to enhance the bioavailability and functional performance of poorly soluble bioactive compounds while maintaining clean-label compatibility, safety, and consumer acceptance. The platform enables ingredient suppliers and consumer product companies to improve potency, reduce dosage requirements, and optimize formulation economics using familiar, regulatory-accepted materials and established manufacturing processes. Supporting multiple engagement models—including consulting, licensing, joint ventures, and direct commercialization—the platform provides a flexible foundation for portfolio expansion, premium positioning, and value creation across global nutrition, functional food, and health-focused consumer markets.

This Abstract is for general business information only and does not disclose enabling technical details.
All rights and disclosures are governed exclusively by the underlying patent application and confidentiality agreements.